Table 1 -.

Clinical characteristics

	BLASST1		LCCC1520
	Nonresponder (N = 9)	Responder (N = 9)	Nonresponder (N = 9)	Responder (N = 9)
Age
Median (Q1, Q3)	67 (59, 69)	63 (57, 71)	71 (63, 73)	64 (61, 66)
Female gender, n (%)	5 (56)	3 (33)	2 (22)	0
Stage, n (%)
T2	8 (89)	8 (89)	6 (67)	7 (77)
T3	1 (11)	0	3 (33)	1 (11)
T4	0	1 (11)	0	1 (11)
Positive N stage, n (%)	1 (11)	1 (11)	0	0
ECOG restricted (1), n (%)	1 (11)	5 (56)	3 (33)	4 (44)
TMB
Median (Q1, Q3)	4.47 (2.43, 6.13)	8.77 (4.20, 10.6)	8.56 (5.02, 10.6)	6.86 (6.00, 9.91)
Missing, n (%)	0	0	2 (22)	1 (11)

ECOG = Eastern Cooperative Oncology Group; TMB = tumor mutational burden.